ROLE OF PRI-MIR-34 B/C AND MIR-146A POLYMORPHISM IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN EGYPTIAN PATIENTS INFECTED WITH HEPATITIS C

Xenobiotics Metabolizing Enzymes Gene Polymorphism and susceptibility of Hepatocellular Carcinoma in Egyptian Patients with Hepatitis C Virus-induced Cirrhosis

Assessment of HFE gene polymorphism effect on the response to the therapy of chronic hepatitis c virus in Egyptians.

The Link between an Epidermal Growth Factor Gene Functional Polymorphism and Hepatocellular Carcinoma in a Cohort of Hepatitis C Egyptian Patients

hTERT rs2736098 Genetic Variants and Susceptibility of Hepatocellular Carcinoma with Chronic Hepatitis C in the Egyptian Patients

The Influence of C936T Gene Polymorphism of the vascular endothelial growth factor and biochemical variants for Alpha-Fetoprotein in hepatocellular carcinoma Patients in Egypt

The relationship between the IL-1β 31gene polymorphism and HCC in Egyptian patients

Monocyte Chemoattractant Protein-1 as a Diagnostic Marker for Detection of Hepatocellular Carcinoma in Egypt

Association Between the ACE (I/D) Gene Polymorphism and Hepatocellular Carcinoma Risk in Egyptian HCV Patients

Polymorphisms of COMT Val158Met and the Risk of Hepatocellular Carcinoma Development among Egyptian HCV Infected Patients